Neoadjuvantes Nivolumab in Kombination mit platinbasierter Chemotherapie bei operablem LungenkrebsNeoadjuvant nivolumab in combination with platinum-based chemotherapy for operable lung cancer

被引：0
|
作者：
Khosro Hekmat
Christiane J. Bruns
机构：
[1] Universität zu Köln,Klinik und Poliklinik für Herz
[2] Universität zu Köln, und Thoraxchirurgie
来源：
Die Chirurgie | 2023年 / 94卷 / 1期
关键词：
D O I：
10.1007/s00104-022-01778-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：1
相关论文
共 50 条
  • [21] FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
    Mathieu, Luckson
    Shah, Sujay
    Pai-Scherf, Lee
    Larkins, Erin
    Vallejo, Jonathon
    Li, Xiaoxue
    Rodriguez, Lisa
    Mishra-Kalyani, Pallavi
    Goldberg, Kirsten B.
    Kluetz, Paul G.
    Theoret, Marc R.
    Beaver, Julia A.
    Pazdur, Richard
    Singh, Harpreet
    ONCOLOGIST, 2021, 26 (05): : 433 - 438
  • [22] Phase II study of induction platinum doublet in combination with nivolumab followed by surgery or concurrent chemotherapy-nivolumab-radiation in unresectable stage IIIA-C non-small cell lung cancer (NSCLC)
    Zinner, Ralph
    Meyerson, Shari L.
    McGarry, Ronald C.
    Mullett, Timothy W.
    Villano, John L.
    Hao, Zhonglin
    Yang, Eddy Shih-Hsin
    Miller, Jordan D.
    Shah-Jadeja, Mansi M.
    Morgan, Clinton T.
    Maskey, Ashish P.
    Bernard, Mark E.
    Yan, Weisi
    Yan, Donglin
    McLouth, Laurie
    Ming-Yuan, Boris
    Cornette, Abagail L.
    Phelps, Mitch A.
    Kneuertz, Peter J.
    Carbone, David Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study
    Clarke, Jeffrey M.
    Patel, Jyoti D.
    Robert, Francisco
    Kio, Ebenezer A.
    Thara, Eddie
    Camidge, D. Ross
    Dunbar, Martin
    Nuthalapati, Silpa
    Dinh, Minh H.
    Bach, Bruce A.
    LUNG CANCER, 2021, 161 : 180 - 188
  • [24] Neoadjuvant nivolumab (NIVO) plus platinum-based chemotherapy in patients with non-metastatic resectable non-small cell lung cancer (NSCLC): The German non- interventional NENI study
    Metzenmacher, M.
    Brueckl, W.
    Buettner, R.
    Griesinger, F.
    Hillejan, L.
    Dauber, K.
    Waldenberger, D.
    Eichhorn, M.
    PNEUMOLOGIE, 2024, 78 : S103 - S103
  • [25] Randomized trial of feiyanning decoction in combination with platinum-based chemotherapy in advanced non-small cell lung cancer patients
    Xu, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S493 - S493
  • [26] Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy
    Wen, Shimin
    Fu, Xi
    Li, Guangming
    He, Lang
    Zhao, Caixia
    Hu, Xin
    Pan, Rongqiang
    Guo, Cuihua
    Zhang, Xinping
    Hu, Xingsheng
    ANTI-CANCER DRUGS, 2016, 27 (05) : 447 - 456
  • [27] EVALUATION OF THE EFFICACY AND SAFETY OF BEVACIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Okada, Asuka
    Fukuoka, Kazuya
    Okuwa, Hisaya
    Kamiya, Hitomi
    Honda, Miki
    Masachika, Eriko
    Otsuki, Taiichiro
    Maeda, Risa
    Hirayama, Noriko
    Terada, Takayuki
    Murakami, Aki
    Yamada, Syusai
    Tamura, Kuninobu
    Tabata, Chiharu
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1202 - S1203
  • [28] Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
    Gadgeel, S.
    Dziubek, K.
    Nagasaka, M.
    Braun, T.
    Hassan, K.
    Cheng, H.
    Wozniak, A.
    Halmos, B.
    Stevenson, J.
    Patil, P.
    Pennell, N.
    Fidler, M. J.
    Bonomi, P.
    Qin, A.
    Niu, Z.
    Nagrath, S.
    Kalemkerian, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S863 - S863
  • [29] Nivolumab as maintenance therapy following platinum-based chemotherapy in EGFR-mutant lung cancer patients after tyrosine kinase inhibitor failure: A single-arm, open-label, phase 2 trial
    Kim, Jiwon
    Choi, Chang-Min
    Ji, Wonjun
    Lee, Jae Cheol
    THORACIC CANCER, 2023, 14 (31) : 3080 - 3088
  • [30] Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naive Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
    Tsuchiya-Kawano, Yuko
    Shiraishi, Yoshimasa
    Kiyomi, Fumiaki
    Okamoto, Isamu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8489 - 8493
12345